These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
808 related articles for article (PubMed ID: 27673361)
1. Medullary Thyroid Carcinoma Associated with Germline RET Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361 [TBL] [Abstract][Full Text] [Related]
2. A Homozygous RET K666N Genotype With an MEN2A Phenotype. Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964 [TBL] [Abstract][Full Text] [Related]
3. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
4. Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476 [No Abstract] [Full Text] [Related]
5. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565 [TBL] [Abstract][Full Text] [Related]
6. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A. Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030 [TBL] [Abstract][Full Text] [Related]
7. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma. Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251 [TBL] [Abstract][Full Text] [Related]
8. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour. Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610 [TBL] [Abstract][Full Text] [Related]
9. The RET mutation E768D confers a late-onset familial medullary thyroid carcinoma -- only phenotype with incomplete penetrance: implications for screening and management of carrier status. Dabir T; Hunter SJ; Russell CF; McCall D; Morrison PJ Fam Cancer; 2006; 5(2):201-4. PubMed ID: 16736292 [TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103 [TBL] [Abstract][Full Text] [Related]
11. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations. Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097 [TBL] [Abstract][Full Text] [Related]
12. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C? Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172 [TBL] [Abstract][Full Text] [Related]
16. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320 [TBL] [Abstract][Full Text] [Related]
17. Surgical strategy in a kindred with a rare RET protooncogene mutation of variable penetrance with regard to multiple endocrine neoplasia. Colombo-Benkmann M; Brämswig J; Höppner W; Gellner R; Hengst K; Böcker W; Senninger N World J Surg; 2002 Oct; 26(10):1286-90. PubMed ID: 12205548 [TBL] [Abstract][Full Text] [Related]
18. Current understanding and management of medullary thyroid cancer. Roy M; Chen H; Sippel RS Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980 [TBL] [Abstract][Full Text] [Related]
20. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation? Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]